U.S. Building Stock News

Lexicon Pharmaceuticals, Inc. reported first-quarter 2026 results on May 7, with revenue rising to US$21.1 million from US$1.26 million a year earlier and net loss narrowing to US$1.04 million from US$25.3 million. Alongside this sharp improvement in quarterly financials, Lexicon recently secured up to US$100 million in non-dilutive debt capacity, extending its funding runway for upcoming regulatory and commercial milestones. With revenue sharply higher and net loss greatly reduced, we’ll...

Recent performance and business snapshot AMN Healthcare Services (AMN) has drawn attention after a sharp move in the stock, with recent returns of 4.8% over the past day, roughly 47% over the past week, and about 66% over the past month. Over the past 3 months the stock is up about 90%, while the year to date gain is about 104% and the 1 year total return is about 42%. These moves come as the company reports annual revenue of US$3,419.3m and a net loss of US$32.4m, alongside annual revenue...

Samsara (NYSE:IOT) has launched multiple new AI-powered solutions tailored for the public sector. The new tools include Ground Intelligence for road condition monitoring, Waste Intelligence for service verification, and Ridership Management for school transportation safety. These products focus on infrastructure, safety, and operational efficiency for government agencies and community organizations. Samsara enters this announcement with its stock at $27.52 and a mixed return profile, with...

ICL Group Ltd has reported its first-quarter 2026 results, posting sales of US$2,023 million and net income of US$126 million, with earnings per share rising to US$0.10 from US$0.07 a year earlier and a cash dividend of US$0.05350 per share approved for June 17, 2026. Beyond the headline beat and guidance upgrade, ICL’s decision to raise full-year adjusted EBITDA expectations while maintaining potash volume targets highlights an emphasis on margin quality, supported by higher-value specialty...

In early May 2026, Niagen Bioscience, Inc. launched its Niagen Plus clinician-directed telehealth platform in the U.S., offering prescription-only, pharmaceutical-grade Niagen via a first-of-its-kind at-home subcutaneous injection kit dispensed through licensed 503A pharmacies. This move marks Niagen Bioscience's first direct-to-client access model, potentially widening its addressable market by combining telehealth, at-home delivery, and injectable NAD+ support under medical...

Ovintiv Inc. has already reported first-quarter 2026 results, with revenue rising to US$2,532 million while a US$630 million net loss reflected large non-cash impairments alongside active portfolio reshaping and a US$0.30 per-share dividend declaration. Amid higher production volumes, reaffirmed 2026 guidance, and resumed share buybacks, Ovintiv paired a wider accounting loss with strong cash generation and an ongoing commitment to returning free cash flow to shareholders. We will now...

In May 2026, Alphatec Holdings director Keith Valentine made substantial insider purchases of NasdaqGS:ATEC shares. At the same time, Alphatec refinanced its debt with a new syndicated bank credit facility. The facility adjusts the company’s interest costs and extends debt maturities, while simplifying its capital structure. Alphatec Holdings, listed on NasdaqGS:ATEC, focuses on spine surgery solutions, a segment that often attracts attention as populations age and demand for orthopedic and...

Envista Holdings stock performance snapshot Envista Holdings (NVST) has seen its stock decline around 1% over the past day and about 12% over the past week, with the move extending to roughly 11% over the past month. Over the past 3 months, the stock is down about 17%. The year-to-date return remains positive at roughly 10%, and the 1-year total return is about 33%. See our latest analysis for Envista Holdings. The recent slide, including a 1-week share price return of down 11.64% and a...

In May 2026, Qnity Electronics reported first‑quarter 2026 results showing net sales rising to US$1.315 billion while GAAP net income and earnings per share fell year over year, but adjusted earnings and margins improved. The company also raised its full‑year 2026 guidance for sales and adjusted earnings, highlighting strong demand from AI and high‑performance computing customers, reinforced by new collaborations with Nvidia and participation in Apple’s American Manufacturing program. Next,...

Investors may be wondering if NOV at around US$20.49 is offering fair value or if the recent enthusiasm has pushed the stock too far, too fast. The stock has posted returns of 1.5% over the last 7 days, 4.4% over the past month, 24.9% year to date and 62.4% over the last year, with a 3 year return of 46.3% and a 5 year return of 35.3%. Recent coverage around NOV has focused on its role in the wider energy sector and how investors are treating equipment and services providers in their...

Earlier in 2026, W. P. Carey reported completing about US$1.10 billion of investments year-to-date, including a major sale-leaseback acquisition of a 43-property GardenCore manufacturing portfolio across 24 U.S. states under a 20-year triple-net master lease with fixed rent escalations. This burst of capital deployment, anchored by the GardenCore deal, gives the REIT visibility into nearly US$1.50 billion of investment volume for 2026, underscoring the scale of its current acquisition...

Why Tractor Supply stock is back in focus Tractor Supply (TSCO) is drawing renewed attention as investors weigh solid fundamentals and ongoing store expansion against headwinds from wholesale cost pressures, weaker real wage growth, and higher gasoline prices pressuring discretionary spending. See our latest analysis for Tractor Supply. That backdrop has weighed heavily on sentiment, with the share price down 34.31% over the past month and the 1 year total shareholder return falling 40.90%,...

DraftKings (NasdaqGS:DKNG) is rolling out its own predictions platform in response to growing competition from prediction market startups. The company is putting substantial capital into technology and marketing to support a unified super app that brings together sportsbook, online gaming, lottery, and prediction markets. New features such as bundled Combos are being introduced as part of a wider shift in DraftKings' business model. DraftKings operates across online sports betting, casino...

Coca-Cola is expanding further into energy and functional drinks, adding new low-sugar and functional products. The company is also moving into ready-to-drink alcohol through Fresca Hard. At the same time, supply chain issues have disrupted Diet Coke availability in India. Coca-Cola, listed as NYSE:KO, is pushing beyond its traditional soda core with activity in energy, functional beverages and ready-to-drink alcohol. The stock trades at $80.26, with returns of 16.1% year to date and 19.4%...

What recent performance suggests about Lincoln Educational Services (LINC) Lincoln Educational Services (LINC) has attracted attention after a recent share price move, with returns over the past month and past 3 months standing at 30.4% and 90.5% respectively. See our latest analysis for Lincoln Educational Services. The recent momentum is strong, with a 15.6% 7 day share price return adding to a 123.2% year to date share price return and a very large 3 year total shareholder return...

Autoliv (ALV) has announced a major restructuring of its EMEA footprint, planning to close its manufacturing operations in Türkiye by the first half of 2028 and record approximately US$142 million in related pre-tax charges. See our latest analysis for Autoliv. The restructuring news comes after a 9.97% 1 month share price return and a 1 year total shareholder return of 22.98%, while the 3 year total shareholder return of 52.54% points to longer term momentum that contrasts with a recent 3...

Activist investors, including Elliott Investment Management and Starboard Value, are reported to have built significant stakes in BILL Holdings (NYSE:BILL). These investors are pushing for a potential sale of the company, with BILL Holdings said to be reviewing strategic alternatives. Private equity firms and software focused buyers are reportedly showing fresh interest in acquiring the company following its valuation reset. BILL Holdings, which last closed at $39.96, is back in focus as...

Axsome Therapeutics recently reported first-quarter 2026 results, with revenue of US$191.2 million and a net loss of US$64.54 million, and earlier in April received U.S. FDA approval for AUVELITY to treat agitation associated with dementia due to Alzheimer’s disease, backed by Phase 3 ADVANCE-1 and ACCORD-2 data. The AUVELITY label expansion creates a new opportunity in Alzheimer’s-related agitation, a highly prevalent, costly, and difficult-to-manage symptom, while Axsome prepares a June...

Huntington Ingalls Industries (HII) is back in focus after first quarter revenue of US$3,099 million surpassed expectations, supported by shipbuilding, along with the delivery of the Flight III destroyer Ted Stevens (DDG 128). See our latest analysis for Huntington Ingalls Industries. At a share price of US$334.22, HII has seen its short term momentum cool, with a 30 day share price return down 15.27% and a 90 day return down 17.83%, even as the 1 year total shareholder return stands at...

ExlService Holdings (NasdaqGS:EXLS) has appointed Bhupender Singh as President and Head of International Growth Markets. Singh will lead expansion across EMEA and APAC, focusing on data and AI-driven services. The move targets growth outside EXL's core US business and reflects an increased focus on international opportunities. For investors tracking NasdaqGS:EXLS, this leadership change comes after a tough share price period. The stock closed at $27.16, with the share price down 12.3% over...

Maze Therapeutics (MAZE) opened Q1 2026 with revenue of US$20 million and a basic EPS loss of US$0.45, alongside a net income loss of US$24.21 million, setting an earnings-season tone that is still firmly focused on managing losses. Over the past few quarters the company has gone from zero reported revenue in each quarter of 2025 to US$20 million in Q1 2026. Quarterly basic EPS has ranged from a loss of US$1.15 in Q1 2025 to a loss of US$0.45 in the latest period, putting the spotlight on how...

Opus Genetics (IRD) opened Q1 2026 with revenue of US$2.2 million and a basic EPS loss of US$0.75, putting a clear focus on how much cash the business is burning to support its growth plans. The company has reported quarterly revenue between US$2.9 million and US$4.4 million over the past five periods, while basic EPS losses have ranged from US$0.12 to US$1.16, giving investors a broad view of how the income statement changes as spending shifts. With profitability still some way off and...

What recent performance tells you about Camden Property Trust (CPT) Camden Property Trust (CPT) has seen its stock move in a mixed pattern recently, with a gain over the past month alongside a decline over the past 3 months and over the past year. See our latest analysis for Camden Property Trust. At a share price of US$105.35, Camden’s recent 1 month share price return of 4.49% contrasts with a year to date share price decline of 4.38% and a 1 year total shareholder return decline of 5.25%...

Resideo Technologies (NYSE:REZI) announced new leadership appointments for both Resideo and its planned spin off, ADI Global Distribution. The company outlined executive and board roles that will govern each business after the separation is complete. The spin off of ADI Global Distribution remains on track for completion between the third and fourth quarters of 2026. Resideo, which focuses on comfort, security and related products and services for homes and businesses, is preparing to...